SEC Form 4 · accession 0001237899-17-000017
REGENERON PHARMACEUTICALS, INC. · REGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
P Roy Vagelos
Officer — Chairman of the Board · Director
Period of report
May 25, 2017
Accepted (ET)
May 26, 2017 · 4:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000872589
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 3, 2017 | G | 571 | $0.00 | D | 151,254 | I | by CLAT |
| Common Stock | Apr 3, 2017 | G | 547 | $0.00 | D | 150,707 | I | by CLAT |
| Common StockF1 | May 25, 2017 | S | 3,510 | $457.58 | D | 89,437 | I | by Spouse as Trustee |
| Common StockF2 | May 25, 2017 | S | 4,985 | $458.35 | D | 84,452 | I | by Spouse as Trustee |
| Common StockF3 | May 25, 2017 | S | 800 | $459.24 | D | 83,652 | I | by Spouse as Trustee |
| Common Stock | holding | — | — | — | 414,156 | D | ||
| Common Stock | holding | — | — | — | 2,300 | I | By 401(k) Plan | |
| Common StockF4 | holding | — | — | — | 1,203 | I | by trust for grandch |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents volume-weighted average price of sales of 3,510 shares of Company stock on May 25, 2017 at prices ranging from $457.05 to $457.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 25, 2017 at each separate price.
- F2Represents volume-weighted average price of sales of 4,985 shares of Company stock on May 25, 2017 at prices ranging from $458.00 to $458.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 25, 2017 at each separate price.
- F3Represents volume-weighted average price of sales of 800 shares of Company stock on May 25, 2017 at prices ranging from $459.01 to $459.53. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 25, 2017 at each separate price.
- F4By a trust for the benefit of certain grandchildren of the reporting person, of which the reporting person and/or the spouse of the reporting person is trustee.